(Q53147673)

English

Severe recalcitrant nail psoriasis responding dramatically to infliximab: report of two patients.

scientific article published on 6 May 2008

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18462438

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/18462438

title

Severe recalcitrant nail psoriasis responding dramatically to infliximab: report of two patients. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18462438

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/18462438

author name string

W Hussain

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18462438

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/18462438

I Coulson

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18462438

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/18462438

C Owen

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18462438

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/18462438

publication date

6 May 2008

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18462438

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/18462438

published in

Clinical and Experimental Dermatology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18462438

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/18462438

volume

33

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18462438

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/18462438

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18462438

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/18462438

page(s)

520-522

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18462438

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/18462438

cites work

Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2008.02738.X

retrieved

21 January 2018

Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2008.02738.X

retrieved

21 January 2018

Identifiers

DOI

10.1111/J.1365-2230.2008.02738.X

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18462438

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/18462438

PubMed publication ID

18462438

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18462438

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/18462438

(Q53147673)

Severe recalcitrant nail psoriasis responding dramatically to infliximab: report of two patients.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)